Margret E Merino MD
Medical Officer, Division of Hematologic Malignancies 2, U.S. Food and Drug Administration
Join to View Full Profile
10903 New Hampshire AveSilver Spring, MD 20993
Dr. Merino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1997 - 2000- National Capital ConsortiumResidency, Pediatrics, 1994 - 1997
New York Medical CollegeClass of 1994
Certifications & Licensure
MD State Medical License 1996 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 31 citationsIrreconcilable Differences: The Divorce Between Response Rates, Progression-Free Survival, and Overall Survival.Margret Merino, Yvette Kasamon, Marc Theoret, Richard Pazdur, Paul Kluetz
Journal of Clinical Oncology. 2023-05-20 - 20 citationsFDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma.Margret Merino, Yvette Kasamon, Hongshan Li, Lian Ma, Ruby Leong
Pediatric Blood & Cancer. 2022-08-01 - 39 citationsSecond Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Ag...Andrew D.J. Pearson, Elly Barry, Yael P. Mosse, Franca Ligas, Nick Bird
European Journal of Cancer. 2021-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
